Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ALLO

Allogene Therapeutics Inc

May 22 • 04:00PM ET

2.00

+0.04 2.04 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: FATE AUTL CRBU NKTX SANA

| Held by: VTI XBI IWM VXF IBB FESM IWN SCHA DFAS VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.77	Insider Own	26.51%	Shs Outstand	345.15M	Perf Week	0.00%
Market Cap	690.31M	Forward P/E	-	EPS next Y	-0.80	Insider Trans	-0.31%	Shs Float	253.64M	Perf Month	-14.89%
Enterprise Value	504.47M	PEG	-	EPS next Q	-0.18	Inst Own	39.26%	Short Float	14.53%	Perf Quarter	-3.85%
Income	-173.76M	P/S	-	EPS this Y	17.63%	Inst Trans	-0.46%	Short Ratio	3.88	Perf Half Y	58.73%
Sales	0.00M	P/B	1.76	EPS next Y	-11.10%	ROA	-38.45%	Short Interest	36.86M	Perf YTD	45.99%
Book/sh	1.14	P/C	2.59	EPS next 5Y	6.46%	ROE	-52.32%	52W High	4.46 -55.16%	Perf Year	83.49%
Cash/sh	0.77	P/FCF	-	EPS past 3/5Y	28.61% 16.08%	ROIC	-49.43%	52W Low	0.98 103.21%	Perf 3Y	-67.16%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.41% 6.39%	Perf 5Y	-92.31%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	37.45%	Oper. Margin	-	ATR (14)	0.17	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	9.65	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	41.48	Recom	1.36
Dividend Gr. 3/5Y	- -	Current Ratio	9.65	EPS Q/Q	36.09%	SMA20	-6.67%	Beta	0.44	Target Price	8.35
Payout	-	Debt/Eq	0.29	Sales Q/Q	-	SMA50	-13.32%	Rel Volume	0.43	Prev Close	1.96
Employees	152	LT Debt/Eq	0.26	Earnings	May 13 AMC	SMA200	19.26%	Avg Volume	9.51M	Price	2.00
IPO	Oct 11, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	5.31% -100.00%	Trades		Volume	4,098,234	Change	2.04%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)